Subscribe to RSS

DOI: 10.1055/s-0044-1791561
Robotic Multivisceral Resection (RMVR) of the Pelvis for Locally Advanced Colorectal Carcinoma: Single Oncosurgical Center Experience
Authors
Abstract
Introduction
Locally advanced colorectal cancer management remains a challenge due to multiple reasons. Some of the major ones include the changes following the use of neoadjuvant radiotherapy and systemic anticancer treatment and previous abdominal surgery (including defunctioning stoma and related changes) and the proximity of structures close to the cancer. Robotic colorectal surgery for malignancy is rapidly evolving as a surgical technique in the management of colorectal cancers but its role in the management of locally advanced disease is not defined.
Methods
This is a retrospective analysis of robotic colorectal surgery performed and captured in a prospective database. Patients who underwent multivisceral robotic colorectal surgery from 2012 to 2022 were included in this study. Robotic colorectal surgeries without multivisceral resections were excluded.
Results
A total of 24 patients underwent robotic multivisceral resection (RMVR). This included 6 males and 17 females. The 17 females underwent posterior clearance, 5 males underwent abdominoperineal resection with seminal vesicle excision, and 1 male underwent total pelvic exenteration. Of the patients, 22 had neoadjuvant pelvic radiotherapy. Sixteen (66.7%) had past lower abdominal surgery (stoma). Preoperative tumor staging was T3 or T4 in 90%, and 80% had R0 resection. The median lymph node harvest was 15 (range 4–31). There was zero need for conversion to open surgery and zero 90-day mortality.
Conclusion
RMVR is a safe approach for locally advanced colorectal cancer, with acceptable surgical clearance.
Publication History
Article published online:
11 December 2024
© 2024. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Guillou PJ, Quirke P, Thorpe H. et al; MRC CLASICC trial group. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet 2005; 365 (9472) 1718-1726
- 2 Kang SB, Park JW, Jeong SY. et al. Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial. Lancet Oncol 2010; 11 (07) 637-645
- 3 Shin JW, Kim J, Kwak JM. et al. First report: robotic pelvic exenteration for locally advanced rectal cancer. Colorectal Dis 2014; 16 (01) O9-O14
- 4 Kazi M, Desouza A, Nashikkar C, Saklani A. Minimally invasive surgery for maximally invasive tumors: pelvic exenterations for rectal cancers. J Minim Invasive Surg 2022; 25 (04) 131-138
- 5 Nguyen Xuan HT, Myriam D, Charlotte N. et al. Pelvic exenteration by robotically-assisted laparoscopy: a feasibility series of 6 cases. Gynecol Oncol Rep 2018; 25 (February): 56-59
- 6 Sun Y, Xu H, Li Z. et al. Robotic versus laparoscopic low anterior resection for rectal cancer: a meta-analysis. World J Surg Oncol 2016; 14 (01) 61
- 7 Rohila J, Kammar P, Pachaury A, de'Souza A, Saklani A. Evolution of robotic surgery in a colorectal cancer unit in India. Indian J Surg Oncol 2020; 11 (04) 633-641
- 8 Bonjer HJ, Deijen CL, Abis GA. et al; COLOR II Study Group. A randomized trial of laparoscopic versus open surgery for rectal cancer. N Engl J Med 2015; 372 (14) 1324-1332
- 9 van der Pas MH, Haglind E, Cuesta MA. et al; COlorectal cancer Laparoscopic or Open Resection II (COLOR II) Study Group. Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial. Lancet Oncol 2013; 14 (03) 210-218
- 10 Manas MJ, Espin E, Lopez-Cano M, Vallribera F, Carrasco AM. Multivisceral resection for locally advanced rectal cancer: prognostic factors influencing outcome. Ann Surg 2015; 235 (02) 217-225
- 11 Lehnert T, Methner M, Pollok A, Schaible A, Hinz U, Herfarth C. Multivisceral resection for locally advanced primary colon and rectal cancer: an analysis of prognostic factors in 201 patients. Ann Surg 2002; 235 (02) 217-225
